Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy

Published:2012-05-01 Issue:10 Volume:42 Page:966-973
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Nishimura Takeshi,Yamaguchi Kanji,Hashimoto Hiroaki,Niimi Toshihisa,Yokomizo Chihiro,Fujii Hideki,Minami Masahito,Sakamoto Masafumi,Ohnish Naoki,Nagao Yasuyuki,Okita Mika,Umemura Atsushi,Shima Toshihide,Okanoue Takeshi,Itoh Yoshito

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Reference26 articles.

1. Management of hepatitis C: report of the consensus meeting at the 45th annual meeting of the Japan society of hepatology 2009;Namiki;Hepatol Res,2010

2. AASLD practice guidelines. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

3. Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads;Sezaki;Dig Dis Sci,2009

4. Predictive value of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study;Okanoue;J Gastroenterol,2009

5. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C;Chayama;Hepatol Res,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP